We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Opko Health Inc (OPK) Com Stk USD 0.01

Sell:$3.85 Buy:$3.86 Change: $0.11 (2.77%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Sell:$3.85
Buy:$3.86
Change: $0.11 (2.77%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Sell:$3.85
Buy:$3.86
Change: $0.11 (2.77%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

OPKO Health, Inc. is a healthcare company. Its segments include Diagnostics and Pharmaceutical. The Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP, hGH-CTP. It also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.

Contact details

Address:
4400 Biscayne Blvd
MIAMI
33137
United States
Telephone:
+1 (305) 5754181
Website:
www.opko.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
OPK
ISIN:
US68375N1037
Market cap:
$2.63 billion
Shares in issue:
681.34 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Phillip Frost
    Chairman of the Board, Chief Executive Officer
  • Jane Hsiao
    Vice Chairman of the Board, Chief Technical Officer
  • Adam Logal
    Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
  • Jon Cohen
    Director and Senior Vice President-OPKO Health, Inc., Executive Chairman-BioReference Laboratories, Inc.
  • Charles Bishop
    Chief Executive Officer of OPKO Renal
  • Tony Cruz
    Chief Executive Officer, Transition Therapeutics, Inc
  • Geoff Monk
    President of BioReference Laboratories
  • Katherine Stueland
    President and Chief Executive Officer of GeneDx, Inc
  • Steven Rubin
    Executive Vice President - Administration, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.